[1]
Rauck, MD, R.L., Bookbinder, MD, S.A., Bunker, MD, T.R., Alftine, MD, C.D., Ghalie, MD, R., Negro-Vilar, MD, PhD, A., de Jong, MD, E. and Gershon, MD, S. 2006. A randomized, open-label study of once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: The extension phase of the ACTION trial. Journal of Opioid Management. 2, 6 (Nov. 2006), 325–333. DOI:https://doi.org/10.5055/jom.2006.0048.